N@N

WEALTHMAKERS.COM Issues Bearish Research Reports on IMGN, KTCC, NOAH, SFE

^{Published on 2013-03-04 08:30:31 - WealthMakers}
 

<div>March 04, 2013 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Immunogen Inc (NASDAQ:IMGN), Key Tronic Corp (NASDAQ:KTCC), Noah Holdings Ltd (NYSE:NOAH), Safeguard Scientifics Inc (NYSE:SFE)

<p>Click here to download each report:</p>

Immunogen Inc (NASDAQ:IMGN): http://www.wealthmakers.com/ireport/22566 Key Tronic Corp (NASDAQ:KTCC): http://www.wealthmakers.com/ireport/22544 Noah Holdings Ltd (NYSE:NOAH): http://www.wealthmakers.com/ireport/22570 Safeguard Scientifics Inc (NYSE:SFE): http://www.wealthmakers.com/ireport/22563

<p>WealthMakers is powered by WOPR (WealthMakers Online Predictive Research), www.wopronline.com , a network of statistical servers with unbridled computing power to analyze exactly what event ( technicals, fundamentals, earnings, seasonality, short squeeze, group rotation, chart patterns, insider buying/selling and multiple other factors) will move each stock, in which direction, to what % degree, in the specific amount of time and with what degree of probability. Based on IBMs work on Deep Blue (now called "Watson"), this powerful database technology matched with hundreds of data feeds and the ability to find patterns, that humans cannot, has the ability to do the work of hundreds or thousands of analysts without getting tired (24 hours per day / 7 days per week). Our unparalleled technology, trading algorithms and proprietary data generate confident predictions, with clear and concise objectives resulting in unique and innovative research reports that move markets and create exponential returns to our clients.</p>

Click here to LIKE us on Facebook:

<p>http://www.facebook.com/pages/WealthMakers-Ltd/165424826916060 </p>

Click here to FOLLOW us on Twitter:

<p>http://www.twitter.com/WealthMakersLtd </p>

Click here to access WealthMakers technology:

<p>http://www.wealthmakers.com/signup.html </p>

Users access these powerful research reports though the PowerTrader Matrix. The Matrix automatically scans through 14,000 stocks, 11 strategies and real-time price updates to find only those stocks that have multiple predictions, at the same time, in the same direction, with no conflicting predictions and the fundamental value of the stock is in-line with the direction of the trade. This powerful technology filters out the exact long/short trades that our trading network need to enter at the precise time and price that they should be entered and exited.

<p>To learn more click here: http://www.buyins.com/woprbrochure.pdf

WealthMakers Power Trader works because the Market Read strategies have a very high success rate. "accuracy", "average return" and "average # of days in trade" are tracked in real-time and documented at www.buyins.com/images/stats.pdf</p>

Immunogen Inc (NASDAQ:IMGN) - ImmunoGen, Inc. engages in the development of antibody-based anticancer therapeutics. The company develops its products using its targeted antibody payload (TAP) technology. Its product candidates include Trastuzumab emtansine, a Phase III clinical trial product for HER2+ metastatic breast cancer; lorvotuzumab mertansine, which is in Phase II clinical trial for the treatment of diagnosed metastatic small-cell lung cancer, as well as in a Phase I clinical trial for the treatment of multiple myeloma; IMGN853, a Phase I clinical trial product that targets over-expressed folate receptor 1 in ovarian cancer and other types of solid tumors, including non-small cell lung cancer; and IMGN529, a product in Phase I clinical trial for treatment of non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia. The company s compounds in earlier-stage of development comprise SAR3419, a Phase II clinical trial product to treat CD19-expressing B-cell malignancies, such as NHL and B-cell acute lymphoblastic leukemia; BT-062, a Phase I product, which targets CD138 antigen found on multiple myeloma and various solid tumors; SAR650984, a Phase I clinical trial product for CD38-targeting hematological malignancies; SAR566658, a Phase I clinical trial product for DS6-expressing solid tumors; BAY 94-9343, a Phase I clinical trial product for mesothelin-expressing solid tumors; and Amgen 1 and Amgen 2, which are phase I clinical trial compounds. It has collaborations with Amgen Inc.; Bayer HealthCare; Biotest AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; Genentech, Inc; Sanofi; and Hoffman-La Roche Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

<p>Key Tronic Corp (NASDAQ:KTCC) - Key Tronic Corporation, doing business as KeyTronicEMS Co., together with its subsidiaries, provides electronic manufacturing services (EMS) and solutions to original equipment manufacturers in the United States, Mexico, and China. Its EMS services include product design, surface mount technologies and pin through hole capability for printed circuit board assembly, tool making, precision plastic molding, liquid injection molding, complex assembly, automated tape winding, prototype design, and full product assembly services. The company also offers integrated electronic and mechanical engineering, precision plastic molding, assembly, component selection, sourcing and procurement, logistics, and product testing and production services. In addition, it manufactures keyboards and other input devices. The company markets its products and services primarily through field sales people and distributors. Key Tronic Corporation was founded in 1969 and is headquartered in Spokane Valley, Washington.</p>

Noah Holdings Ltd (NYSE:NOAH) - Noah Holdings Limited, through its subsidiaries and variable interest entity, engages in the distribution of OTC wealth management products to the high net worth population in China. It markets and distributes various categories of products supplied by third party product providers, based on the underlying assets class, such as fixed income products, including collateralized fixed income products sponsored by trust companies and other products that provide investors with fixed rates of return; private equity funds products comprising investments in private equity funds sponsored by domestic and internal fund management firms; securities investment funds, which are privately raised funds investing in publicly traded stocks; and investment-linked insurance products. The company also offers proprietary wealth management products, such as private equity fund of funds; and provides various value-added services to clients, including financial planning, product analysis and recommendation, product and market updates, and investor education. It serves high net worth individuals; enterprises affiliated with high net worth individuals; and wholesale clients, primarily local commercial banks or branches of national commercial banks that distribute wealth management products to their own clients. The company was incorporated in 2007 and is headquartered in Shanghai, China.

<p>Safeguard Scientifics Inc (NYSE:SFE) - Safeguard Scientifics, Inc. is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. The firm prefers to make investments in companies engaged in the technology and life sciences sectors. Within the technology sector, it invests in software as a service, enterprise 3.0, technology enabled services, internet/new media, financial services information technology, healthcare information technology and selected business services with capital requirements of up to $25 million. Within the life sciences sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, and specialty pharmaceuticals, and selected healthcare services. It invests throughout United States and Southeastern Canada. The firm primarily invests between $10 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of five percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. It was formerly known as Lancaster Corporation. Safeguard Scientifics, Inc. was founded in 1953 and is based in Wayne, Pennsylvania with an additional office in Weston, Massachusetts.</p>

About WEALTHMAKERS

<p>Wealthmakers Online Predictive Research (WOPR) is a distributed computing system that has hundreds of data feeds (economic, weather, geopolitical, interest rates, energy, equities, currencies, commodities, etc.) feeding into a relational database that searches for patterns and determines how a trading instrument has behaved both before and after specific events have taken place in the past. Only about 25% of stocks display patterns at any given time and only about 1% of stocks exhibit all the necessary conditions on any given day to make a trade. That means that out of 14,000 stocks, only about 140 trades are high probability trades that our system would generate a research report on and disseminate the information to clients. This process eliminates the noise and only tells you which stocks have multiple strategies lining up at the same time, in the same direction, with no conflicting predictions and the fundamental valuation is in-line with the prediction!</p>

Strategies include:

<p>EARNINGS - Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predict probability, price move and length of move before and after all US stock earnings reports.</p>

FRICTION FACTOR - Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.

<p>GATS - The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.</p>

GROUP SECTOR - Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.

<p>PATTERN SCANNER - describes the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.</p>

EVENTS - This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock or its perceived value among analysts ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.

<p>RegSHO NAKED SHORTS - SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.</p>

SEASONALITY - Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.

<p>SQUEEZETRIGGER - Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.</p>

VALUATION - A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.

<p>INSIDER - Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements, up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.</p>

DISCLAIMER:

<p>WEALTHMAKERS is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. WEALTHMAKERS has not been compensated by any of the above mentioned companies specifically for this report. Past performance is not indicative of future results. Please visit our web site, www.wealthmakers.com , for complete risks and disclosures. </p>

Contact:

WEALTHMAKERS 1-516-858-1113 tom@wealthmakers.com www.wealthmakers.com

</div>